UK reviewing Palantir's NHS contract amid pressure to use break clause

Britain is reviewing a major contract with American firm Palantir for the National Health Service. The government must decide by early 2027 whether to continue the deal. Concerns about patient data privacy and reliance on a foreign supplier are ce...

UK reviewing Palantir's NHS contract amid pressure to use break clause
Britain is conducting a full review of its National Health Service contract with US data analytics firm Palantir, amid growing political pressure for the government to use a break clause at the end of the initial term in early 2027.

Technology minister Liz Kendall said on Tuesday the review would assess whether to extend the £330 million ($441 million) deal under ‌provisions allowing the ⁠government to ⁠continue it for up to seven years or terminate it.

"The current health secretary is reviewing every ​single aspect of that (contract) to make sure we get the right deal for Britain," Kendall ​told Times Radio, referring to concerns about patient confidentiality, public trust and reliance on a U.S. supplier.


The contract, awarded in 2023 to build a platform linking NHS ​data, runs until early 2027, when the government must ⁠decide whether ‌to extend it.

Parliamentary criticism

A parliamentary committee last week urged ministers ​to trigger the ​clause and end the contract, warning Palantir's role represents an "unacceptable ⁠point of weakness" and highlighting risks from relying on a ​small number of U.S. tech firms.
ADVERTISEMENT

The committee said the company's ​growing role in the public sector raised concerns about dependence on overseas suppliers and the resilience of critical services, while noting officials reported benefits in areas such as waiting list management, operations and hospital discharge planning.

The deal has also drawn scrutiny because Palantir supplies software to the US military and immigration authorities, and ‌over the political views of its billionaire co-founder Peter Thiel, an early supporter of President Donald Trump.

Campaigners and unions have raised concerns ​about the handling ​of sensitive health ⁠data. Last month, the Financial Times reported NHS officials had proposed granting some external staff, including Palantir personnel, broad administrative access to identifiable patient data on parts of ​the system.

Palantir has said its software helps improve patient care and efficiency across the NHS.
ADVERTISEMENT

Neither Palantir nor NHS England immediately responded to requests for comment.

Separately, London Mayor Sadiq Khan last month blocked a £50 million police contract with Palantir, citing concerns about value for money and whether companies' ethics should be considered in public procurement.
ADVERTISEMENT

($1 = 0.7486 pounds)
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Tech › Tech & Internet › UK reviewing Palantir's NHS contract amid pressure to use break clause
Text Size:AAA
Success
This article has been saved

*

+